135 related articles for article (PubMed ID: 37939428)
21. Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model.
Kong P; Yang H; Tong Q; Dong X; Yi MA; Yan D
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10685-10700. PubMed ID: 37306737
[TBL] [Abstract][Full Text] [Related]
22. Tumor-associated Macrophages as Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon Cancer.
Feng Q; Chang W; Mao Y; He G; Zheng P; Tang W; Wei Y; Ren L; Zhu D; Ji M; Tu Y; Qin X; Xu J
Clin Cancer Res; 2019 Jul; 25(13):3896-3907. PubMed ID: 30988081
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of programmed cell death ligand 1 (PD-L1) for hepatocellular carcinoma: a meta-analysis.
Li XS; Li JW; Li H; Jiang T
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32255189
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value and predictive biomarkers of phenotypes of tumour-associated macrophages in colorectal cancer.
Kou Y; Li Z; Sun Q; Yang S; Wang Y; Hu C; Gu H; Wang H; Xu H; Li Y; Han B
Scand J Immunol; 2022 Apr; 95(4):e13137. PubMed ID: 34964155
[TBL] [Abstract][Full Text] [Related]
25. Macrophage profile in primary versus secondary liver tumors.
Avădănei ER; Wierzbicki PM; Giuşcă SE; Grigoraş A; Amălinei C; Căruntu ID
Folia Histochem Cytobiol; 2014; 52(2):112-23. PubMed ID: 25007179
[TBL] [Abstract][Full Text] [Related]
26. The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma.
Kong LQ; Zhu XD; Xu HX; Zhang JB; Lu L; Wang WQ; Zhang QB; Wu WZ; Wang L; Fan J; Tang ZY; Sun HC
PLoS One; 2013; 8(3):e59771. PubMed ID: 23555776
[TBL] [Abstract][Full Text] [Related]
27. Elevated CD163
Yang C; Wei C; Wang S; Shi D; Zhang C; Lin X; Dou R; Xiong B
Int J Biol Sci; 2019; 15(5):984-998. PubMed ID: 31182919
[No Abstract] [Full Text] [Related]
28. Prognostic significance of tumor-associated macrophages in patients with nasopharyngeal carcinoma: A meta-analysis.
Chen YL
Medicine (Baltimore); 2020 Sep; 99(39):e21999. PubMed ID: 32991403
[TBL] [Abstract][Full Text] [Related]
29. Pathologic assessment of tumor-associated macrophages and their histologic localization in invasive breast carcinoma.
Mwafy SE; El-Guindy DM
J Egypt Natl Canc Inst; 2020 Jan; 32(1):6. PubMed ID: 32372332
[TBL] [Abstract][Full Text] [Related]
30. The prognostic value of tumour-associated macrophages in Non-Hodgkin's lymphoma: A systematic review and meta-analysis.
Xu X; Li Z; Liu J; Zhu F; Wang Z; Wang J; Zhang J; Wang H; Zhai Z
Scand J Immunol; 2020 Jan; 91(1):e12814. PubMed ID: 31419843
[TBL] [Abstract][Full Text] [Related]
31. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
[TBL] [Abstract][Full Text] [Related]
32. Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes.
Kuroda H; Jamiyan T; Yamaguchi R; Kakumoto A; Abe A; Harada O; Masunaga A
Clin Transl Oncol; 2021 Dec; 23(12):2513-2525. PubMed ID: 34089486
[TBL] [Abstract][Full Text] [Related]
33. Prognostic role of macrophages and mast cells in the microenvironment of hepatocellular carcinoma after resection.
Ali E; Červenková L; Pálek R; Ambrozkiewicz F; Hošek P; Daum O; Liška V; Hemminki K; Trailin A
BMC Cancer; 2024 Jan; 24(1):142. PubMed ID: 38287290
[TBL] [Abstract][Full Text] [Related]
34. Immunologic cellular characteristics of the tumour microenvironment of hepatocellular carcinoma drive patient outcomes.
Atanasov G; Dino K; Schierle K; Dietel C; Aust G; Pratschke J; Seehofer D; Schmelzle M; Hau HM
World J Surg Oncol; 2019 Jun; 17(1):97. PubMed ID: 31170995
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Implication of M2 Macrophages Are Determined by the Proportional Balance of Tumor Associated Macrophages and Tumor Infiltrating Lymphocytes in Microsatellite-Unstable Gastric Carcinoma.
Kim KJ; Wen XY; Yang HK; Kim WH; Kang GH
PLoS One; 2015; 10(12):e0144192. PubMed ID: 26714314
[TBL] [Abstract][Full Text] [Related]
36. Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma.
Guo B; Cen H; Tan X; Ke Q
BMC Med; 2016 Oct; 14(1):159. PubMed ID: 27745550
[TBL] [Abstract][Full Text] [Related]
37. Tumor-associated macrophage infiltration and prognosis in colorectal cancer: systematic review and meta-analysis.
Li J; Li L; Li Y; Long Y; Zhao Q; Ouyang Y; Bao W; Gong K
Int J Colorectal Dis; 2020 Jul; 35(7):1203-1210. PubMed ID: 32303831
[TBL] [Abstract][Full Text] [Related]
38. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
39. Cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway.
Chen S; Morine Y; Tokuda K; Yamada S; Saito Y; Nishi M; Ikemoto T; Shimada M
Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195849
[TBL] [Abstract][Full Text] [Related]
40. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
